-+ 0.00%
-+ 0.00%
-+ 0.00%

Q32 Bio Inks Securities Purchase Agreement With New, Current Institutional Investors For ~$55M Private Placement Of Common Stock, Pre-Funded Warrants

Benzinga·05/27/2026 12:04:16
Listen to the news

Q32 Bio Inc. (NASDAQ:QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that it has entered into a securities purchase agreement with certain new and existing institutional and accredited investors for the private placement of common stock and pre-funded warrants for an aggregate of approximately $55 million.